Mariner’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.8K Sell
39,346
-2,879
-7% -$3.54K ﹤0.01% 3437
2025
Q4
$53.3K Sell
42,225
-26,781
-39% -$37.3K ﹤0.01% 3410
2025
Q3
$107K Buy
69,006
+44,914
+186% +$61.7K ﹤0.01% 3342
2025
Q2
$31.8K Buy
24,092
+6,629
+38% +$9.06K ﹤0.01% 3384
2025
Q1
$29K Buy
+17,463
New +$28.8K ﹤0.01% 3347
2023
Q4
Sell
-11,979
Closed -$19.2K 3145
2023
Q3
$19.2K Buy
11,979
+1,871
+19% +$3.41K ﹤0.01% 2844
2023
Q2
$21.9K Buy
+10,108
New +$15.8K ﹤0.01% 2771
2023
Q1
Sell
-49,535
Closed -$62K 2855
2022
Q4
$62K Buy
+49,535
New +$78.1K ﹤0.01% 2589
2019
Q3
Sell
-78,213
Closed -$191K 938
2019
Q2
$191K Buy
+78,213
New +$171K ﹤0.01% 1050

Other funds holding OPK

Mariner's OPK Position: Q1 2026 in Review

Mariner reduced its Opko Health (OPK) stake by 6.8% in Q1 2026, selling an estimated $3.54K and leaving 39,346 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3437.

Mariner first reported a position in OPK in Q2 2019 and has held it in 9 quarters since. The position peaked at $191K in Q2 2019. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Mariner held 39,346 shares of Opko Health worth $44.8K as of Q1 2026.
  • Mariner sold 2,879 Opko Health shares in Q1 2026, an estimated $3.54K.
  • Opko Health made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3437 holding.
  • Mariner first reported a position in Opko Health in Q2 2019 and has held it in 9 quarters since.
  • Mariner's Opko Health position peaked at $191K in Q2 2019.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.